Top compounds associated with response to DLST


Feature Type Standardized
Nominal ANOVA
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.0075 0.8
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.0072 0.8
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0074 0.8
mRNA BYL-719 CTRPv2 pan-cancer AAC 0.0086 0.8
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC 0.0077 0.8
mRNA NSC-87877 GDSC1000 pan-cancer AAC 0.007 0.8
mRNA Curcumin CTRPv2 pan-cancer AAC -0.0068 0.8
mRNA BEC CTRPv2 pan-cancer AAC 0.015 0.8
mRNA Sildenafil CTRPv2 pan-cancer AAC 0.0076 0.8
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.0085 0.8
Download CSV